IMRN
Price
$1.94
Change
-$0.00 (-0.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
13.45M
68 days until earnings call
TCRX
Price
$1.84
Change
+$0.06 (+3.37%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
101.01M
40 days until earnings call
Interact to see
Advertisement

IMRN vs TCRX

Header iconIMRN vs TCRX Comparison
Open Charts IMRN vs TCRXBanner chart's image
Immuron
Price$1.94
Change-$0.00 (-0.00%)
Volume$505
Capitalization13.45M
TScan Therapeutics
Price$1.84
Change+$0.06 (+3.37%)
Volume$7.34K
Capitalization101.01M
IMRN vs TCRX Comparison Chart in %
Loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRN vs. TCRX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a Buy and TCRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (IMRN: $1.93 vs. TCRX: $1.78)
Brand notoriety: IMRN and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRN: 59% vs. TCRX: 87%
Market capitalization -- IMRN: $13.45M vs. TCRX: $101.01M
IMRN [@Biotechnology] is valued at $13.45M. TCRX’s [@Biotechnology] market capitalization is $101.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMRN and TCRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 6 TA indicator(s) are bullish while TCRX’s TA Score has 3 bullish TA indicator(s).

  • IMRN’s TA Score: 6 bullish, 2 bearish.
  • TCRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, IMRN is a better buy in the short-term than TCRX.

Price Growth

IMRN (@Biotechnology) experienced а +6.63% price change this week, while TCRX (@Biotechnology) price change was +3.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.98%. For the same industry, the average monthly price growth was +9.31%, and the average quarterly price growth was +51.82%.

Reported Earning Dates

IMRN is expected to report earnings on Dec 03, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($101M) has a higher market cap than IMRN($13.4M). IMRN YTD gains are higher at: 13.529 vs. TCRX (-41.447). IMRN has higher annual earnings (EBITDA): -7.35M vs. TCRX (-130.55M). TCRX has more cash in the bank: 218M vs. IMRN (7.74M). TCRX has higher revenues than IMRN: TCRX (6.96M) vs IMRN (6.54M).
IMRNTCRXIMRN / TCRX
Capitalization13.4M101M13%
EBITDA-7.35M-130.55M6%
Gain YTD13.529-41.447-33%
P/E RatioN/AN/A-
Revenue6.54M6.96M94%
Total Cash7.74M218M4%
Total DebtN/A96.7M-
FUNDAMENTALS RATINGS
IMRN: Fundamental Ratings
IMRN
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRNTCRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNENF4.950.08
+1.75%
Ganfeng Lithium Group Co. Ltd.
MRIRF0.07N/A
N/A
Route 109 Resources Inc.
BKQNY9.46N/A
N/A
Bank of Queensland Ltd.
HBUV1.30N/A
N/A
Hubilu Venture Corporation
MIAPF10.00N/A
N/A
MINTO APT REAL ESTATE INVT TR

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with LABFF. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
+0.52%
LABFF - IMRN
81%
Closely correlated
N/A
MNMD - IMRN
44%
Loosely correlated
-0.51%
VYGR - IMRN
26%
Poorly correlated
-3.76%
CELZ - IMRN
25%
Poorly correlated
+4.50%
TCRX - IMRN
24%
Poorly correlated
-3.26%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-3.26%
MGNX - TCRX
46%
Loosely correlated
-4.07%
FATE - TCRX
44%
Loosely correlated
-3.88%
CRBU - TCRX
41%
Loosely correlated
-9.39%
EYPT - TCRX
41%
Loosely correlated
-6.32%
ABOS - TCRX
40%
Loosely correlated
+16.54%
More